Skip to main content

Institutional filer profile

Redmile Biopharma Investments III L.P. Insider Trades

Latest reported as Corporate insider of Attovia Therapeutics, Inc. (ATTO).

Purchase filings
1
Reported companies
1
Net open-market value
$10,200,000
Latest transaction
Aug 6, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 6, 2026Attovia Therapeutics, Inc. (ATTO)Corporate insiderOpen Market Purchase600,000$17.00$10,200,000